In 2004 a sample of peptides from nine different adult amphibians in Omar Torrijos National Park, Panama were taken to test for susceptibility to Chytridiomycosis. Of the 9 species test the "A. lemur" ranked third in immunologic resistance with a mean of 15% in inhibition of pathogen growth and peptide renewal. The strongest (Xenopus Laevis) had a mean of 65% more than four times that of the "A. lemur". Although "A. Lemur" shows some resiliance to chytridiomycosis it is not completely immune. In a different study following that, it was predicted that this species could survive chytridiomycosis because they contained dermaseptin-L1 and phylloseptin-L1 peptides which contained resistance to gram-negative and gram-positive bacteria. While there has been survivors, the appearance of chytridiomycosis still caused population decline despite their antimicrobial skin peptides. This shows that in-vitro studies may not represent what actually happens in living organisms.